Study of an mRNA flu vaccine for adults
Part of Infections, Lungs & breathing clinical trials.
This trial is testing a new mRNA-based flu vaccine in healthy adults. It aims to see if the vaccine is safe and effective at preventing influenza.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy and medically stable.
- You have not had the flu in the last 5 months.
- You have not received any flu vaccine (licensed or investigational) in the last 5 months.
- You have not taken antiviral flu medications like Tamiflu in the last 5 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This trial tests a new quadrivalent influenza (flu) vaccine in adults 18 and older. It aims to see if the vaccine is safe and helps protect against the flu. You may be able to join if you are generally healthy and have not had the flu or a flu shot recently.
This trial tests a flu vaccine (split virus type) for adults aged 60+ to see how well it works and how safe it is. It might help protect older adults from the flu.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study tests if a new nasal spray flu vaccine is safe and effective for preventing flu in healthy adults aged 18 to 59. If you've had the flu recently or have certain health conditions, this trial may not be for you.
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
Hear when a new Healthy Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.